Warby Parker Inc.
NYSE:WRBYMedical - Instruments & Supplies
+$0.92 today
- Market cap
- $3.07B
- Beta
- 1.97
- P/E (TTM)
- 2305.1
- EPS (TTM)
- $0.01
Volume 5.90M
Average 2.81M
WRBY EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Warby Parker Inc.NYSE: WRBY
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $19.32M rose 94.3% year over year, ahead of the +56.0% change in trailing-twelve-month EBITDA. Sequentially, it rose 8.8% from the prior quarter.
Context
- EBITDA amounted to 6.1% of revenue in FY2025, up 2.7 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 10 analysts of $116.58M (+118.6%) for the fiscal year ending Dec 2026, a step up from the +102.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $19.32M+8.8% QoQ
- Last fiscal yearDec 2025
- $53.32M+102.4% YoY
- LTMJun 2026
- $63.38M+56.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +94.3% | +50.3% | -44.0 pp |
| 1 year | +102.4% | +118.6% | +16.3 pp |
| 3-year CAGR | — | +55.8% | — |
| 5-year CAGR | +40.8% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 53.32M USD
- Year-over-year change
- +102.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 53.32M | +102.4% |
| FY2024 | 2024-12-31 | 26.35M | +208.8% |
| FY2023 | 2023-12-31 | (24.21M) | +69.0% |
| FY2022 | 2022-12-31 | (78.03M) | +36.1% |
| FY2021 | 2021-12-31 | (122.14M) | — |
EBITDA vs competitors
How WRBY compares with its peers on the latest reported figures
- WRBY's LTM Jun 2026 EBITDA of $63.38M is the 7th highest of the 10 companies compared; the peer median is $247.61M.
- Its year-over-year change of +56.0% is the 3rd highest of 10, against a peer median of +5.8%.
- EBITDA amounts to 7.0% of revenue for WRBY, versus a peer median of 19.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.05B | -37.3% | +3.4% | 18.9% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $478.53M | +19.3% | +7.4% | 20.5% |
| LTM Jul 2026 | $313.03M | +5.8% | +10.2% | 17.0% | |
| LTM Jun 2026 | $261.21M | -30.7% | +1.0% | 19.3% | |
| LTM Jun 2026 | $247.61M | -23.3% | +17.3% | 11.5% | |
| LTM Mar 2026 | $96.3M | +31.7% | +35.0% | 37.6% | |
| LTM Jun 2026 | $63.38M | +56.0% | — | 7.0% | |
| LTM Jun 2026 | -$63.18M | +83.2% | — | 40.5% | |
| LTM Mar 2026 | -$127M | +74.8% | — | 3.5% | |
| LTM Mar 2026 | -$548.8M | -290.2% | — | 20.7% | |
| Peer median (excluding WRBY) | $247.61M | +5.8% | +8.8% | 19.3% | |
Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 540.8M | 598.11M | 669.77M | 771.32M | 871.91M |
| Cost of Revenue | 223.05M | 257.05M | 304.54M | 344.48M | 401.33M |
| Gross Profit | 317.75M | 341.06M | 365.22M | 426.83M | 470.58M |
| Gross Margin | 58.8% | 57.0% | 54.5% | 55.3% | 54.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 461.41M | 452.27M | 421.57M | 440.05M | 475.92M |
| Operating Expenses | 461.41M | 452.27M | 437.22M | 456.95M | 475.92M |
| Depreciation & Amortization | 21.87M | 31.86M | 38.55M | 45.87M | 50.28M |
| EBITDA | (122.14M) | (78.03M) | (24.21M) | 26.35M | 53.32M |
| EBITDA Margin | -22.6% | -13.0% | -3.6% | 3.4% | 6.1% |
| Operating Income | (143.66M) | (111.2M) | (72M) | (30.11M) | (5.34M) |
| Operating Margin | -26.6% | -18.6% | -10.7% | -3.9% | -0.6% |
| Interest Income | 0 | 1.31M | 9.23M | 10.6M | 8.38M |
| Interest Expense | 347K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (347K) | 1.31M | 9.23M | 10.6M | 8.38M |
| Income Before Tax | (144.01M) | (109.9M) | (62.76M) | (19.52M) | 3.04M |
| Pre-Tax Margin | -26.6% | -18.4% | -9.4% | -2.5% | 0.3% |
| Income Tax Expense | 263K | 497K | 433K | 875K | 1.4M |
| Net Income | (144.27M) | (110.39M) | (63.2M) | (20.39M) | 1.64M |
| Net Margin | -26.7% | -18.5% | -9.4% | -2.6% | 0.2% |
| EPS (Basic) | (1.39) | (0.96) | (0.54) | (0.17) | 0.01 |
| EPS (Diluted) | (1.39) | (0.96) | (0.54) | (0.17) | 0.01 |
| Weighted Avg Shares | 113.62M | 114.94M | 117.39M | 120.39M | 122.67M |
| Weighted Avg Shares (Diluted) | 113.62M | 114.94M | 117.39M | 120.39M | 125.1M |
Warby Parker Inc.
NYSE:WRBY
Intrinsic Alpha fair value
Locked
Current Price
$28.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.